FDA to Discuss Ban on Menthol in Tobacco Products

Dec.30.2022
FDA to Discuss Ban on Menthol in Tobacco Products
FDA to hold workshop on banning menthol flavor in tobacco products on January 12, 2023.

On January 12, 2023, the US Food and Drug Administration (FDA) will hold a workshop on the ban of flavored tobacco products, specifically regarding the use of menthol as a flavoring in tobacco products. The proposed tobacco product standard is to "prohibit the use of menthol as a characterizing flavor in cigarettes and cigars on a scientific basis," marking the first tobacco-related workshop of 2023.


The FDA presentation will provide scientific evidence to inform the development of these proposed regulations and explain the highly impactful scientific assessments used by the FDA to review them.


Bridget Ambrose, the Director of Population Health Science at the FDA's Center for Tobacco Products (CTP) Office of Science (OS), will be delivering a speech. Ambrose has over 20 years of experience in tobacco control and regulatory science, and has expertise in longitudinal analyses of tobacco use.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool
UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool
In correspondence with 20isPlenty campaigners, the government agreed nicotine pouches are likely to pose lower health risks than smoking and confirmed they are a harm reduction tool, while warning about their high nicotine content, fast absorption and potential to be flavoured.
Jan.06 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
Azerbaijan’s Milli Majlis to hold public hearings on e-cigarette use in the 2026 spring session
Azerbaijan’s Milli Majlis to hold public hearings on e-cigarette use in the 2026 spring session
Azerbaijan’s Milli Majlis will hold public hearings regarding the use of e-cigarettes. The topic has been included in the 2026 spring session work plan of the Milli Majlis Committee on Agrarian Policy. During the spring session, the committee plans to convene a public hearing titled “Health is our goal: an end to e-cigarettes.”
Jan.23 by 2FIRSTS.ai
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
The vaping brand OXBAR has recently listed its open-system, refillable pod device OX35K on its official website. The product features a “2ml built-in pod + two 10ml external refill bottles” e-liquid supply structure and supports top refilling, with a claimed puff count of up to 35,000. It is equipped with a 1000mAh built-in battery and offers dual power modes—BOOST and ECO—positioning the device to balance high-puff performance with an open-system form factor.
Jan.13 by 2FIRSTS.ai
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco has launched a limited-edition Ploom AURA front panel series in collaboration with musician Ichiro Yamaguchi, featuring five customized designs incorporating brass, Kutani ware, verdigris, kintsugi, and rosewood motifs. Two editions are available through retail channels, while three are distributed via a membership lottery system. The initiative highlights JT’s growing focus on exterior customization and design partnerships as part of its broader heated tobacco brand strategy.
Feb.11 by 2FIRSTS.ai